Generon (Shanghai) Corporation
Shanghai
About Generon (Shanghai) Corporation
Generon (Shanghai) Corporation Ltd. is an integrated biotech company developing therapeutic biologics for patients world-wide. Their research & development center is located in Zhang Jiang High-Tech Park, Shanghai, China. their cGMP drug manufacturing facility is located in Economic-Technological Development Area, Beijing, China. Their mission is “Innovating for Life” to develop innovative therapeutic biologics for global patients with unmet medical needs. They employ their proprietary, cutting-edge technology platforms to discover, develop and manufacture biologic therapeutics. They are focused on “best-in-class” and “first-in-class” recombinant therapeutic proteins to treat cancer, autoimmune and inflammatory diseases. They follow international quality standards for their product development and adhere to regulatory requirements of the CFDA, FDA and EMA. “Innovation and quality” are the soul of Generon in the generation of scientific data and in the processes of drug discovery, development and manufacturing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $70.0M
- Last round: Series Unknown (Jun 2022)
- Website: generonbiomed.comen
- Phone: 8621-61760866,61760850
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/generon-shanghai-corporation-127386 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.